Gureje O, Von Korff M, Simon GE, Gater R. Persistent pain and well-being: a World Health Organization study in primary care. JAMA. 1998;280(2):147-151.
Raofi S, Schappert SM. Medication therapy in ambulatory medical care: United States, 2003-04. Vital Health Stat 13. 2006(163):1-40.
Tick H, Nielsen A, Pelletier KR, et al. Evidence-based Nonpharmacologic Strategies for Comprehensive Pain Care: The Consortium Pain Task Force White Paper. Explore (NY). 2018;14(3):177-211.
Institute of Medicine, Committee on Advancing Pain Research, Care and Education. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington (DC): National Academies Press (US); 2011.
Gaskin DJ, Richard P. The economic costs of pain in the United States. J Pain. 2012;13(8):715-724.
GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545-1602.
hhs.gov. Help, resources and information: national opioids crisis; the opioid epidemic in numbers. 2018; https://www.hhs.gov/opioids/ Accessed January 6, 2019.
Shah A, Hayes CJ, Martin BC. Characteristics of initial prescription episodes and likelihood of long-term opioid use - United States, 2006-2015. MMWR Morb Mortal Wkly Rep. 2017;66(10):265-269.
Manchikanti L, Kaye AM, Knezevic NN, et al. Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines. Pain Physician. 2017;20(2s):S3-s92.
National Academies of Sciences Engineering and Medicine. Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use (2017). Washington, DC: The National Academies Press. doi: https://doi.org/10.17226/24781; 2017.
Singh G, Triadafilopoulos G. Epidemiology of NSAID induced gastrointestinal complications. J Rheumatol Suppl. 1999;56:18-24.
Singh G, Ramey DR, Morfeld D, Shi H, Hatoum HT, Fries JF. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study. Arch Intern Med. 1996;156(14):1530-1536.
Singh G. Gastrointestinal complications of prescription and over-the-counter nonsteroidal anti-inflammatory drugs: a view from the ARAMIS database. Arthritis, Rheumatism, and Aging Medical Information System. Am J Ther. 2000;7(2):115-121.
Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain--United States, 2016. JAMA. 2016;315(15):1624-1645.
U.S. Food and Drug Administration. Introduction FDA’s Opioid Analgesic REMS Education Blueprint for Health Care Providers Involved in the Treatment and Monitoring of Patients with Pain (January 2018). 2018; https://www.fda.gov/media/99496/download. Accessed June 10, 2019, 2019.
Office of the Army Surgeon General. Pain Management Task Force Final Report May 2010. 2010; http://www.dvcipm.org/site/assets/files/1070/pain-task-force-final-report-may-2010.pdf Accessed May 24, 2017.
Qaseem A, Wilt TJ, McLean RM, Forciea MA. Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2017;166(7):514-530.
Skelly AC, Chou R, Dettori JR, et al. AHRQ Comparative Effectiveness Reviews. Noninvasive Nonpharmacological Treatment for Chronic Pain: A Systematic Review [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Jun. (Comparative Effectiveness Review, No. 209. ) Available from: https://www.ncbi.nlm.nih.gov/books/NBK519953/ 2018.
Nahin RL, Boineau R, Khalsa PS, Stussman BJ, Weber WJ. Evidence-based evaluation of complementary health approaches for pain management in the United States. Mayo Clin Proc. 2016;91(9):1292-1306.
The Joint Commission. Clarification of the pain management standard. 2015; https://www.jointcommission.org/assets/1/18/Clarification_of_the_Pain_Management__Standard.pdf. Accessed May 22, 2019.
Pain Management - Leadership Responsibilities for Providing Nonpharmacologic Modalities for Managing Pain - LD.04.03.13 EP 2 2019; https://www.jointcommission.org/standards/standard-faqs/critical-access-hospital/leadership-ld/000002158/. Accessed July 26, 2019, 2019.